This morning, Lifco AB reported its Q2 results. At the time of writing, the stock’s down 9% (after being as much as 13%) as soft organic growth and mix headwinds resulted in a quite notable organic EBITA decline (likely around -6% excl. FX).
Overall, Lifco’s 1H results remained fairly consistent with its post-COVID performance, although that’s a subpar achievement for the leading Swedish serial acquirer. This is reflected in the below graph, showing its annual EBITA by segment including the 1H 2025 rolling twelve months figures.
Let’s take a closer look at the results and share our view on why investor expectations remain largely imbalanced, creating significant potential downside risk. We explicitly state potential as we don’t think we can time reversals in valuation nor do we think price targets out loud. For us, it’s simple: if the forward return outlook doesn’t look much appealing, then we just move on and focus on better opportunities instead.